The drugmaker plans to launch Semaglutide in 87 countries next year, including those where patents are expiring and emerging ...

What I’m thinking, as someone who owns Eli Lilly for the Charitable Trust and who wishes I owned PepsiCo, is that there might ...

Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance coverage has fueled a risky but growing “gray” market for purchasing active ...

Mini meals with bite size portions are meant to appeal to people taking GLP-1 weight-loss drugs that reduce appetite.

With the sales of weight-loss drugs booming, India is now the epicentre of the global obesity treatment market, reports The ...

Older adults and women using Wegovy for obesity management may be more likely to lose lean mass, although increasing protein intake may help protect against lean mass loss, according to a speaker.

The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But GLP-1s can be an effective reinforcement of diet and exercise.

A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...

As Cipla turns 90, the pharmaceutical giant is reimagining itself as a brand fit for a wellness-driven, digital-first India.

It's hard to ignore the signs that thinness is once again the body ideal. With increased engagement on posts that are often disguised as 'wellness' content, here's how you can protect yourself from 't ...

Employers are looking for ways to manage costs, cover popular weight loss drugs and offer well-being and mental health ...